Compare VOR & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | TII |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 231.0M |
| IPO Year | 2021 | N/A |
| Metric | VOR | TII |
|---|---|---|
| Price | $15.70 | $4.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $64.78 | $6.00 |
| AVG Volume (30 Days) | ★ 1.1M | 895.9K |
| Earning Date | 11-13-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $75,461,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.77 |
| Revenue Growth | N/A | ★ 54.36 |
| 52 Week Low | $2.62 | $0.26 |
| 52 Week High | $65.80 | $4.47 |
| Indicator | VOR | TII |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | N/A |
| Support Level | $13.00 | N/A |
| Resistance Level | $14.64 | N/A |
| Average True Range (ATR) | 1.45 | 0.00 |
| MACD | 0.30 | 0.00 |
| Stochastic Oscillator | 97.28 | 0.00 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Titan Mining Corp is a Canadian natural resources company. It is engaged in the acquisition, exploration, and development of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States. The Company operates one reportable segment, mineral production and exploration in the United States.